PRELUDE THERAPEUTICS INC (PRLD) Stock News
NASDAQ:PRLD - US74065P1012 - Common Stock
1.23 USD
+0.09 (+7.89%)
PRLD Latest News, Press Relases and Analysis
All
Press Releases
23 days ago - By: The Motley Fool
23 days ago - By: Prelude Therapeutics, Incorporated
23 days ago - By: Prelude Therapeutics, Incorporated
3 months ago - By: Prelude Therapeutics, Incorporated
3 months ago - By: Prelude Therapeutics, Incorporated
4 months ago - By: Prelude Therapeutics, Incorporated
4 months ago - By: Prelude Therapeutics, Incorporated
4 months ago - By: Prelude Therapeutics, Incorporated
4 months ago - By: Prelude Therapeutics, Incorporated
4 months ago - By: Prelude Therapeutics, Incorporated
4 months ago - By: Prelude Therapeutics, Incorporated
6 months ago - By: Prelude Therapeutics, Incorporated
6 months ago - By: Prelude Therapeutics, Incorporated
6 months ago - By: Prelude Therapeutics, Incorporated
6 months ago - By: Prelude Therapeutics, Incorporated
9 months ago - By: Prelude Therapeutics, Incorporated
9 months ago - By: Prelude Therapeutics, Incorporated
9 months ago - By: Prelude Therapeutics, Incorporated
9 months ago - By: Prelude Therapeutics, Incorporated
10 months ago - By: Prelude Therapeutics, Incorporated
11 months ago - By: Prelude Therapeutics, Incorporated
11 months ago - By: Prelude Therapeutics, Incorporated
a year ago - By: Prelude Therapeutics, Incorporated
a year ago - By: Prelude Therapeutics, Incorporated
a year ago - By: Prelude Therapeutics, Incorporated
a year ago - By: Prelude Therapeutics, Incorporated